Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: TRANSPHORM, INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Advanced Research Projects Agency
Period of performance: 2021-09-02 to 2024-02-28
Current total value of award: $1423455.39
Description: DARPA SMALL BUSINESS INNOVATION RESEARCH PROGRAM (SBIR) PHASE II EFFORT ENTITLED, "N-POLAR GAN/SAPPHIRE FOR MM-WAVE POWER ELECTRONICS"